236 related items for PubMed ID: 16133041
1. High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity.
Ohtomo Y, Fujinaga S, Takada M, Murakami H, Akashi S, Shimizu T, Kaneko K, Yamashiro Y.
Pediatr Nephrol; 2005 Dec; 20(12):1744-9. PubMed ID: 16133041
[Abstract] [Full Text] [Related]
2. Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration.
Fujinaga S, Hirano D, Nishizaki N, Someya T, Ohtomo Y, Ohtsuka Y, Shimizu T, Kaneko K.
Pediatr Nephrol; 2011 Mar; 26(3):479-83. PubMed ID: 21174219
[Abstract] [Full Text] [Related]
3. Long-term outcome of Japanese children with complicated minimal change nephrotic syndrome treated with mycophenolate mofetil after cyclosporine.
Fujinaga S, Hirano D, Nishino T, Umeda C, Watanabe Y, Nakagawa M.
Pediatr Nephrol; 2019 Nov; 34(11):2417-2421. PubMed ID: 31435725
[Abstract] [Full Text] [Related]
4. Effect of single-dose oral mizoribine pulse therapy twice per week for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M, Ishihara M, Morita T, Hayashi A, Okada S, Ohta T, Sakano T, Wakiguchi H.
Clin Nephrol; 2012 Jul; 78(1):40-6. PubMed ID: 22732336
[Abstract] [Full Text] [Related]
5. Oral mizoribine pulse therapy for patients with steroid-resistant and frequently relapsing steroid-dependent nephrotic syndrome.
Kawasaki Y, Hosoya M, Kobayashi S, Ohara S, Onishi N, Takahashi A, Isome M, Suzuki H.
Nephrol Dial Transplant; 2005 Oct; 20(10):2243-7. PubMed ID: 16030039
[Abstract] [Full Text] [Related]
6. Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome.
Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB.
Pediatr Nephrol; 2003 Aug; 18(8):833-7. PubMed ID: 12774223
[Abstract] [Full Text] [Related]
7. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases.
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[Abstract] [Full Text] [Related]
8. Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
Gregory MJ, Smoyer WE, Sedman A, Kershaw DB, Valentini RP, Johnson K, Bunchman TE.
J Am Soc Nephrol; 1996 Apr; 7(4):543-9. PubMed ID: 8724887
[Abstract] [Full Text] [Related]
9. Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome.
Mizutani A, Fujinaga S, Sakuraya K, Hirano D, Shimizu T.
Clin Exp Nephrol; 2019 Feb; 23(2):244-250. PubMed ID: 30121800
[Abstract] [Full Text] [Related]
10. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S, Takemura T, Okada M, Murakami K, Yagi K, Fukushima K, Yoshioka K.
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[Abstract] [Full Text] [Related]
11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
12. Novel multidrug therapy for children with cyclosporine-resistant or -intolerant nephrotic syndrome.
Aizawa-Yashiro T, Tsuruga K, Watanabe S, Oki E, Ito E, Tanaka H.
Pediatr Nephrol; 2011 Aug; 26(8):1255-61. PubMed ID: 21479767
[Abstract] [Full Text] [Related]
13. Effect of oral mizoribine pulse therapy for frequently relapsing steroid-dependent nephrotic syndrome.
Fujieda M, Ishihara M, Morita T, Hayashi A, Utsunomiya Y, Ohta T, Sakano T, Wakiguchi H.
Clin Nephrol; 2008 Mar; 69(3):179-84. PubMed ID: 18397716
[Abstract] [Full Text] [Related]
14. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suzuki K, Ito E, Waga S.
Clin Nephrol; 2005 Oct; 64(4):258-63. PubMed ID: 16240896
[Abstract] [Full Text] [Related]
15. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
Pediatr Int; 2015 Oct; 57(1):85-91. PubMed ID: 25225083
[Abstract] [Full Text] [Related]
16. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[Abstract] [Full Text] [Related]
17. Cyclosporine therapy monitored with abbreviated area under curve in nephrotic syndrome.
Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G.
Pediatr Nephrol; 2005 Jan; 20(1):25-9. PubMed ID: 15602664
[Abstract] [Full Text] [Related]
18. Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy.
Kuroyanagi Y, Gotoh Y, Kasahara K, Nagano C, Fujita N, Yamakawa S, Yamamoto M, Takeda A, Uemura O.
Clin Exp Nephrol; 2018 Apr; 22(2):413-419. PubMed ID: 28699031
[Abstract] [Full Text] [Related]
19. [Beneficial and adverse effects of high-dosage MZR therapy in the management of children with frequently relapsing nephrotic syndrome].
Goto M, Ikeda M, Hataya H, Ishikura K, Hamasaki Y, Honda M.
Nihon Jinzo Gakkai Shi; 2006 Apr; 48(4):365-70. PubMed ID: 16780106
[Abstract] [Full Text] [Related]
20. Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?
Fujinaga S, Ohtomo Y, Someya T, Shimizu T, Yamashiro Y, Kaneko K.
Clin Nephrol; 2008 Feb; 69(2):84-9. PubMed ID: 18218301
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
